Plain-English translation of NCT07290140 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a paclitaxel-coated balloon device, used after standard sinus surgery, can help people with chronic rhinosinusitis (a long-lasting sinus inflammation that doesn't respond well to medications) have better symptom relief. Half of the participants will receive standard sinus surgery alone, while the other half will receive sinus surgery followed by treatment with the medication-coated balloon in their affected sinuses. Researchers want to see if this medication helps prevent symptoms from returning.
Chronic rhinosinusitis is a stubborn condition that often comes back even after surgery and medical treatment. This trial is exploring whether the new treatment can reduce inflammation and help patients stay symptom-free longer than surgery alone.
You likely qualify if…
You likely don't qualify if…
You will undergo endoscopic sinus surgery (a minimally invasive procedure using a camera and small instruments). Depending on which group you're randomly assigned to, you'll either have surgery alone, or surgery followed by placement of the drug-coated balloon in your treated sinuses. You will then return for follow-up visits and assessments over the next year to monitor your symptoms, healing, and overall sinus health.
AI-generated summary from trial data · Aug 25, 2026 · Not medical advice
United States